Market Overview

DOJ Drops DaVita Inquiry



DaVita Inc. (NYSE: DVA) announced that the United States Attorney's
Office (USAO) for St. Louis recently informed the company that the USAO
completed its investigation and is not taking any action against the

In March 2005, the St. Louis USAO initiated its inquiry with a subpoena
and subsequent document requests in connection with a joint civil and
criminal investigation. The broad requests covered a range of topics
including financial relationships with physicians and joint ventures.
They also covered other services provided to patients, including the
administration and billing of Epogen®. DaVita® fully cooperated with the
government investigation, providing hundreds of thousands of documents.
The USAO closed its investigation without filing any charges, without

See full press release

Posted-In: News Guidance Asset Sales Management Global


Related Articles (DVA)

View Comments and Join the Discussion!

Partner Center